CASI Pharmaceuticals (CASI) Releases Quarterly Earnings Results
CASI Pharmaceuticals (NASDAQ:CASI) announced its earnings results on Thursday. The company reported ($0.06) earnings per share for the quarter, AnalystRatings.Net reports.
CASI Pharmaceuticals (NASDAQ:CASI) opened at 1.86 on Thursday. CASI Pharmaceuticals has a one year low of $1.45 and a one year high of $2.34. The stock has a 50-day moving average of $1.81 and a 200-day moving average of $1.82. The company’s market cap is $50.3 million.
CASI Pharmaceuticals Inc, formerly EntreMed, Inc, is a clinical-stage pharmaceutical company. Its drug candidate is ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.